A review of data on daprodustat and vadadustat from randomized controlled trials in Japanese patients with anemia in CKD along with the clinical rationale for use of the HIF stabilizer class.

Peter L. Salgo, MD: I know that there’s a new class of medications. They’re not just wiggles on the old stuff. These are the HIF [hypoxia-inducible factor] stimulators, stabilizers, and that’s hypoxia ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Let's start with what causes anemia of ...

CINCINNATI, May 12, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular ...

Anemia is an important complication of kidney disease and remains a challenge to treat. Traditionally used erythropoietin-stimulating agents (ESAs) are often ineffective, and increasing doses are ...